Product nameAnti-Respiratory Syncytial Virus antibody
See all Respiratory Syncytial Virus primary antibodies
DescriptionGoat polyclonal to Respiratory Syncytial Virus
Tested applicationsSuitable for: ELISA, ICC/IF, Inhibition Assaymore details
Species reactivityReacts with: Respiratory syncytial virus
Respiratory Syncytial Virus isolate, confirmed.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
Storage bufferPreservative: 0.1% Sodium Azide
Constituents: PBS, pH 7.2
Concentration information loading...
Our Abpromise guarantee covers the use of ab20531 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Inhib: 1/256 (Fusion Inhibition).
Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
RelevanceRespiratory syncytial virus (RSV) is a major cause of respiratory illness in young children. RSV infection produces a variety of signs and symptoms involving different areas of the respiratory tract, from the nose to the lungs. RSV is a negative sense, enveloped RNA virus. The virion is variable in shape and size with average diameter of between 120 and 300 nm. The 63 kD RSV fusion protein of the RSS 2 strain (subtype A) directs fusion of viral and cellular membranes, results in viral penetration, and can direct fusion of infected cells with adjoining cells, resulting in the formation of syncytia or multi nucleated giant cells.
Cellular localizationVirion. Host cytoplasm
- Entrez Gene: 2829063 Respiratory syncytial virus
- RS virus antibody
- RSV antibody
This product has been referenced in:
- McCutcheon KM et al. The Interferon Type I/III Response to Respiratory Syncytial Virus Infection in Airway Epithelial Cells Can Be Attenuated or Amplified by Antiviral Treatment. J Virol 90:1705-17 (2015). Read more (PubMed: 26608311) »
- Fonseca W et al. A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus. Arch Virol 159:1067-77 (2014). Read more (PubMed: 24292020) »